BIOMAT Database Logo BIOMAT Database Logo

Factors influencing macrophage activation by muramyl peptides: inhibition of NO synthase activity by high levels of NO. 1994

C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Laboratoire de Pharmacotechnie-Biopharmacie, URA CNRS 1218, Université de Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.

Treatment with muramyldipeptide (MDP) or a lipophilic derivative (MTP-Chol) included in nanocapsules renders macrophages cytostatic towards tumor cells. At the same time, nitric oxide (NO) synthase (EC 1.14.23) activity is induced, as determined by measurement of the two end products of the reaction (nitrite and L-citrulline). The objective of this study was to investigate some factors which might influence this activation and explain the decreased response observed at high nanocapsule concentrations. The glucose content of the medium did not seem to be limiting. Addition of indomethacin decreased nitrite production in the effector phase, suggesting a role for prostaglandins in the maintenance of the activated state. We also tested the hypothesis that NO itself might regulate inducible nitric oxide synthase activity. The addition of NO donors (SIN-1 and nitrosoglutathione) or superoxide dismutase to cultures of activated macrophages inhibited the NO synthase activity. Since these NO donors were non toxic towards macrophages, these observations indicate clearly that the addition of exogenous NO to that formed by the enzymatic reaction can cause inhibition of the inducible NO synthase.

UI MeSH Term Description Entries
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D005260 Female Females
D000119 Acetylmuramyl-Alanyl-Isoglutamine Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity. Mur-NAc-L-Ala-D-isoGln,Muramyl Dipeptide,Acetylmuramyl Alanyl Isoglutamine,N-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-Amide,N-Acetylmuramyl-L-Alanyl-D-Isoglutamine,Alanyl Isoglutamine, Acetylmuramyl,Dipeptide, Muramyl,Isoglutamine, Acetylmuramyl Alanyl,Mur NAc L Ala D isoGln,N Acetyl Muramyl L Alanyl D Glutamic alpha Amide,N Acetylmuramyl L Alanyl D Isoglutamine
D000594 Amino Acid Oxidoreductases A class of enzymes that catalyze oxidation-reduction reactions of amino acids. Acid Oxidoreductases, Amino,Oxidoreductases, Amino Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016676 Macrophages, Alveolar Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells. Alveolar Macrophages,Macrophages, Pulmonary,Pulmonary Macrophages,Macrophage, Pulmonary,Pulmonary Macrophage,Alveolar Macrophage,Macrophage, Alveolar
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019001 Nitric Oxide Synthase An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE. NO Synthase,Nitric-Oxide Synthase,Nitric-Oxide Synthetase,Nitric Oxide Synthetase,Oxide Synthase, Nitric,Synthase, Nitric Oxide

Related Publications

C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Inhibition of macrophage migration by muramyl peptides.
May 1979, Infection and immunity,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Liposome encapsulation of muramyl peptides for activation of macrophage cytotoxic properties.
January 1986, Methods in enzymology,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Macrophage activation by tuftsin and muramyl-dipeptide.
December 1981, Molecular and cellular biochemistry,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Inhibition of macrophage migration by synthetic muramyl dipeptide.
February 1978, Biochemical and biophysical research communications,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment.
January 1980, Microbiology and immunology,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Relationship between NO-synthase activity and TNF-alpha secretion in mouse macrophage lines stimulated by a muramyl peptide entrapped in nanocapsules.
January 1996, International journal of immunopharmacology,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
January 1984, International journal of tissue reactions,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Macrophage activation by muramyl dipeptide (MDP) without lymphocyte participation.
January 1981, Microbiology and immunology,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Factors influencing the levels of fatty acid synthase complex activity in fowl.
January 1999, Biochemistry and molecular biology international,
C Morin, and H Fessi, and J P Devissaguet, and F Puisieux, and G Barratt
Macrophage activation for antitumour function by muramyl dipeptide-protein conjugates.
January 1990, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!